期刊文献+

补元汤加味对慢性阻塞性肺疾病稳定期BODE指数的影响 被引量:7

Effect of Modified Buyuan Decoction on BODE Index in Patients with Chronic Obstructive Pulmonary Disease in Stable Stage
在线阅读 下载PDF
导出
摘要 目的:观察补元汤加味对慢性阻塞性肺疾病BODE指数的影响。方法:将60例符合慢性阻塞性肺疾病稳定期诊断标准的患者,随机分为治疗组及对照组,每组各30例。治疗组服用中药汤剂:补元汤加味,每日1剂。对照组按需使用吸入型支气管舒张剂:可必特。两组观察时间均为6个月。每2个月对患者BODE指数各因素进行跟踪检测:体重指数、FEV1测定、呼吸困难分级、6min步行距离。动态观察两种治疗对各因素的影响程度及BODE指数水平的变化,并比较差异性。结果:治疗6个月后,治疗组与对照组相比较,FEV1%pred、6min步行距离(6MWT)、体重指数(BMI)、呼吸困难以及BODE指数改善明显(P<0.05)。治疗组在6个月的治疗过程中,随着疗程的增加,各项因素及BODE指数水平改善更加显著。结论:补元汤加味能有效改善COPD稳定期患者肺功能、运动耐力、营养状况及BODE指数,BODE指数是一项客观、系统的COPD稳定期疗效评价指标。 Objective : To observe the effect of modified Buyuan Decoction on the BODE index in patients with chronic obstrutive pulmonary disease in stable stage. Methods:60 patients who met the Diagnostic Criteria for COPD in stable stage were randomly and equally divided into the treatment group (30 patients) and control group (30 patients) . The treatment group was given traditional Chinese medicine: modified Buyuan Decoction, one dose per day, while the control group was given Compound Ipratropium Bromide according to need. Six months are needed for clinical observation for the two groups. Then the factors of patient in every two months, such as body mass index (BMI), FEV1, dyspnea grades, sixminute walking distance (6MWT) were tested. The changes in various factors and BODE index between two groups were compared. Results : After 6 months' treatment, compared with those in the control group or before therapy, the levels of the various factors and BODE index in the treatment group were significantly improved( P 〈0.05 ), and the levels of the various factors and BODE index improved greatly with the increase of the treatment. Conclusion : Clinical studies with modified Buyuan Decoction can improve lung function, exercise capacity, nutritional status and BODE index. BODE index is an objective and systematic evaluating indicator for curative effect in patients with chronic obstructive pulmonary disease in stable stage.
出处 《辽宁中医杂志》 CAS 2012年第3期482-485,共4页 Liaoning Journal of Traditional Chinese Medicine
基金 江西省教育厅青年科学基金项目(GJJ09547)
关键词 补元汤 慢性阻塞性肺疾病 稳定期 BODE指数 Buyuan Decoction chronic obstructive puhnonary disease stable stage BODE index
  • 相关文献

参考文献10

二级参考文献35

  • 1洪广祥.中医药治疗慢性阻塞性肺疾病的几点思考[J].中华中医药杂志,2005,20(1):16-19. 被引量:95
  • 2王秋月,许惟元,程青,康健,于润江.慢性阻塞性肺疾病患者生活质量影响因素分析(英文)[J].中国现代医学杂志,2005,15(4):493-496. 被引量:14
  • 3Mannino DM,Homa DM,Akinbami LJ,et al.Chronic obstructive pulmonary disease surveillance-United States,1971-2000.Respir Care,2002,47:1184-1199.
  • 4Murray C J,Lopez AD.Mortality by cause for eight regions of the world:Global Burden of disease study.Lancet,1997,349:1269-1276.
  • 5Ceili BR,Cote CG,Matin JM,et al.The body-mass index,airflow obstruction,dyspnea,end exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
  • 6Mahler D,Wells C.Evaluation of clinical methods for rating dyspnea.Chest,1989,93:580-586.
  • 7Sethi S.Pathogenesis and treatment of acute exacerbations of chronic obstructive pulmonary disease.Semin Respir Crit Care Med,2005,26:192-203.
  • 8Celli BR,MacNee W.ATS/ERS Task Force Standards for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
  • 9Wouter EF,Cretzberg EC,Schols AM.Systemic effects in COPD.Chest,2002,121:127S-130S.
  • 10Sahebjami H,Sathianpitayakul E.Inflence of body weight on the severity of dyspnea in chronic obstructive pulmonary disease.Am J Bespir Crit Care Med,2000,161:886-890.

共引文献456

同被引文献61

引证文献7

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部